AKT1 and B-cell chronic lymphocytic leukemia: In contrast to results obtained with CD40 + IL-4, when CLL cells were stimulated to proliferate by CD154 + IL-21, pharmacological inhibition of AKT reduced proliferation in most but not all patient samples indicating an inconsistent role for AKT in signalling proliferation under these circumstances.